<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To describe our experience of post-transplant <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infections</z:e> in allogeneic stem cell transplants at the Armed Forces Bone Marrow Transplant Centre, Rawalpindi, Pakistan </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: From July 2001 to September 2006, patients with malignant and non-malignant <z:e sem="disease" ids="C0947743,C0018939" disease_type="Disease or Syndrome" abbrv="">hematological disorders</z:e> having human leukocyte antigen (HLA)-matched sibling donors were selected for transplant </plain></SENT>
<SENT sid="2" pm="."><plain>Pre-transplant <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> surveillance was carried out, and strict prophylaxis against <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> was observed </plain></SENT>
<SENT sid="3" pm="."><plain>After admission to the hospital, patients were kept in protective isolation rooms, equipped with a HEPA filter positive-pressure laminar airflow ventilation system </plain></SENT>
<SENT sid="4" pm="."><plain>Bone marrow and/or peripheral blood stem cells were used as the stem cell source </plain></SENT>
<SENT sid="5" pm="."><plain>Cyclosporin and <z:chebi fb="2" ids="8378">prednisolone</z:chebi> were used as prophylaxis against <z:e sem="disease" ids="C0018133" disease_type="Disease or Syndrome" abbrv="GVH">graft-versus-host disease</z:e> (GVHD) </plain></SENT>
<SENT sid="6" pm="."><plain>The engraftment was monitored with cytogenetic/molecular analysis and change of blood group </plain></SENT>
<SENT sid="7" pm="."><plain>Survival was calculated from the date of transplant to <z:hpo ids='HP_0011420'>death</z:hpo> or last follow-up </plain></SENT>
<SENT sid="8" pm="."><plain>RESULTS: One hundred and fifty-four patients received allogeneic stem cell transplants from HLA-matched siblings for various <z:e sem="disease" ids="C0947743,C0018939" disease_type="Disease or Syndrome" abbrv="">hematological disorders</z:e> at the Armed Forces Bone Marrow Transplant Centre, Rawalpindi, Pakistan between July 2001 and September 2006 </plain></SENT>
<SENT sid="9" pm="."><plain>Indications for transplant included <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> (n=66), <z:e sem="disease" ids="C0002875" disease_type="Disease or Syndrome" abbrv="">beta-thalassemia major</z:e> (n=40), <z:hpo ids='HP_0011010'>chronic</z:hpo> myeloid <z:hpo ids='HP_0001909'>leukemia</z:hpo> (n=33), <z:hpo ids='HP_0002488'>acute leukemia</z:hpo> (n=8), and miscellaneous disorders (n=7) </plain></SENT>
<SENT sid="10" pm="."><plain>One hundred and twenty patients were male and 34 were female </plain></SENT>
<SENT sid="11" pm="."><plain>The median age of the patient cohort was 14 years (range 1 1/4-54 years) </plain></SENT>
<SENT sid="12" pm="."><plain>One hundred and thirty-six patients and 135 donors were cytomegalovirus (CMV) IgG-positive </plain></SENT>
<SENT sid="13" pm="."><plain>One hundred and forty patients (90.9%) developed febrile episodes in different phases of post-transplant recovery </plain></SENT>
<SENT sid="14" pm="."><plain>Infective organisms were isolated in 150 microbiological culture specimens out of 651 specimens from different sites of <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infections</z:e> (23.0% culture positivity) </plain></SENT>
<SENT sid="15" pm="."><plain>Post-transplant <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infections</z:e> were confirmed in 120 patients (77.9%) on the basis of clinical assessment and microbiological, virological, and histopathological examination </plain></SENT>
<SENT sid="16" pm="."><plain>Mortality related to <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infections</z:e> was 13.0% </plain></SENT>
<SENT sid="17" pm="."><plain>Fatal <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infections</z:e> included CMV disease (100% mortality, 6/6), <z:e sem="disease" ids="C0004032" disease_type="Disease or Syndrome" abbrv="">disseminated aspergillosis</z:e> (66.7% mortality, 4/6), pseudomonas <z:mpath ids='MPATH_681'>septicemia</z:mpath> (42.9% mortality, 9/21), and <z:e sem="disease" ids="C0041296" disease_type="Disease or Syndrome" abbrv="tb|tbc">tuberculosis</z:e> (25% mortality, 1/4) </plain></SENT>
<SENT sid="18" pm="."><plain>CONCLUSIONS: More than 90% of our patients developed febrile episodes with relatively low culture yield </plain></SENT>
<SENT sid="19" pm="."><plain>The majority of <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infections</z:e> were treated effectively, however CMV, <z:e sem="disease" ids="C0004030" disease_type="Disease or Syndrome" abbrv="">aspergillosis</z:e>, and <z:e sem="disease" ids="C0033817" disease_type="Disease or Syndrome" abbrv="">pseudomonas infections</z:e> remained problematic with high mortality </plain></SENT>
</text></document>